Michael F. Christman, Ph.D.
President and Chief Executive Officer
Coriell Institute for Medical Research
Dr. Michael Christman joined Coriell Institute in 2007 and initiated the Coriell Personalized Medicine Collaborative (CPMC), which now involves more than 8,500 participants in 48 states, multiple hospital partners and numerous research collaborators. Under his leadership, Coriell launched Coriell Life Sciences to provide a medication management tool for clinical use and established a federally-funded Induced Pluripotent Stem Cell lab. Prior to Coriell, Dr. Christman served as professor and founding chair of the Department of Genetics and Genomics for Boston University School of Medicine.